
ORENCIA
ABATACEPT
- Concentración
- 125mg/250mg
- Fabricante
- BRISTOL-MYERS SQUIBB Pharma
- Disponibilidad
- Disponible para obtener
ABATACEPT 125mg/250mg — Injection, 1's Vial
¿Necesita ayuda?
Nuestro equipo de soporte multilingüe puede ayudarle con disponibilidad, envío y pedidos.
Chatear por WhatsApp
Escanear para WeChat
Sobre este medicamento
Originator: ORENCIA by Bristol-Myers Squibb Company. · Manufacturer: BRISTOL-MYERS SQUIBB Pharma. Indication & Dosage: ORENCIA (ABATACEPT), is a prescription medication used to treat of autoimmune diseases such as moderate to severe rheumatoid arthritis, psoriatic arthritis, and polyarticular juvenile idiopathic arthritis. It works by selectively modulating the immune response through inhibition of T-cell activation, thereby reducing inflammation, joint damage, and other symptoms associated with these chronic inflammatory conditions. ORENCIA Manufactured by BRISTOL MYERS SQUIBB Pharma Ltd. in USA. Abatacept is administered by a healthcare professional as an intravenous infusion over approximately 30 minutes, initially at weeks 0, 2, and 4, followed by maintenance doses every 4 weeks thereafter. Side Effects: The most common adverse reactions are: Headache, nausea, cough, dizziness, and mild injection site reactions such as redness, itching, or pain. The above information comes from the Internet. Please consult with doctor for medical advice.
Indicaciones
Esta información es solo de referencia y no constituye consejo médico. Consulte siempre a un profesional de la salud calificado.



